IBDEI1MV ; ; 19-NOV-2015
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;JUN 29, 2015
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,99) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,27328,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,27328,1,3,0)
 ;;=3^Hyperkalemia
 ;;^UTILITY(U,$J,358.3,27328,1,4,0)
 ;;=4^E87.5
 ;;^UTILITY(U,$J,358.3,27328,2)
 ;;=^60041
 ;;^UTILITY(U,$J,358.3,27329,0)
 ;;=E89.2^^132^1312^48
 ;;^UTILITY(U,$J,358.3,27329,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,27329,1,3,0)
 ;;=3^PostProcedural Hypoparathyroidism
 ;;^UTILITY(U,$J,358.3,27329,1,4,0)
 ;;=4^E89.2
 ;;^UTILITY(U,$J,358.3,27329,2)
 ;;=^5003037
 ;;^UTILITY(U,$J,358.3,27330,0)
 ;;=E89.6^^132^1312^47
 ;;^UTILITY(U,$J,358.3,27330,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,27330,1,3,0)
 ;;=3^PostProcedural Adrenocortical Hypofunction
 ;;^UTILITY(U,$J,358.3,27330,1,4,0)
 ;;=4^E89.6
 ;;^UTILITY(U,$J,358.3,27330,2)
 ;;=^5003042
 ;;^UTILITY(U,$J,358.3,27331,0)
 ;;=L68.0^^132^1312^25
 ;;^UTILITY(U,$J,358.3,27331,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,27331,1,3,0)
 ;;=3^Hirsutism
 ;;^UTILITY(U,$J,358.3,27331,1,4,0)
 ;;=4^L68.0
 ;;^UTILITY(U,$J,358.3,27331,2)
 ;;=^5009262
 ;;^UTILITY(U,$J,358.3,27332,0)
 ;;=M80.00XA^^132^1312^2
 ;;^UTILITY(U,$J,358.3,27332,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,27332,1,3,0)
 ;;=3^Age-Related Osteoporosis w/ Fx,Unspec Site,Init Encntr
 ;;^UTILITY(U,$J,358.3,27332,1,4,0)
 ;;=4^M80.00XA
 ;;^UTILITY(U,$J,358.3,27332,2)
 ;;=^5013363
 ;;^UTILITY(U,$J,358.3,27333,0)
 ;;=M81.0^^132^1312^3
 ;;^UTILITY(U,$J,358.3,27333,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,27333,1,3,0)
 ;;=3^Age-Related Osteoporosis w/o Fx
 ;;^UTILITY(U,$J,358.3,27333,1,4,0)
 ;;=4^M81.0
 ;;^UTILITY(U,$J,358.3,27333,2)
 ;;=^5013555
 ;;^UTILITY(U,$J,358.3,27334,0)
 ;;=M85.80^^132^1312^44
 ;;^UTILITY(U,$J,358.3,27334,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,27334,1,3,0)
 ;;=3^Osteopenia,Unspec Site
 ;;^UTILITY(U,$J,358.3,27334,1,4,0)
 ;;=4^M85.80
 ;;^UTILITY(U,$J,358.3,27334,2)
 ;;=^5014473
 ;;^UTILITY(U,$J,358.3,27335,0)
 ;;=N62.^^132^1312^24
 ;;^UTILITY(U,$J,358.3,27335,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,27335,1,3,0)
 ;;=3^Gynecomastia
 ;;^UTILITY(U,$J,358.3,27335,1,4,0)
 ;;=4^N62.
 ;;^UTILITY(U,$J,358.3,27335,2)
 ;;=^5015790
 ;;^UTILITY(U,$J,358.3,27336,0)
 ;;=E10.43^^132^1312^6
 ;;^UTILITY(U,$J,358.3,27336,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,27336,1,3,0)
 ;;=3^DM Type 1 w/ Diabetic Autonomic Polyneuropathy
 ;;^UTILITY(U,$J,358.3,27336,1,4,0)
 ;;=4^E10.43
 ;;^UTILITY(U,$J,358.3,27336,2)
 ;;=^5002607
 ;;^UTILITY(U,$J,358.3,27337,0)
 ;;=E10.59^^132^1312^4
 ;;^UTILITY(U,$J,358.3,27337,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,27337,1,3,0)
 ;;=3^DM Type 1 w/ Circulatory Complications
 ;;^UTILITY(U,$J,358.3,27337,1,4,0)
 ;;=4^E10.59
 ;;^UTILITY(U,$J,358.3,27337,2)
 ;;=^5002612
 ;;^UTILITY(U,$J,358.3,27338,0)
 ;;=E10.618^^132^1312^5
 ;;^UTILITY(U,$J,358.3,27338,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,27338,1,3,0)
 ;;=3^DM Type 1 w/ Diabetic Arthropathy
 ;;^UTILITY(U,$J,358.3,27338,1,4,0)
 ;;=4^E10.618
 ;;^UTILITY(U,$J,358.3,27338,2)
 ;;=^5002614
 ;;^UTILITY(U,$J,358.3,27339,0)
 ;;=E10.621^^132^1312^7
 ;;^UTILITY(U,$J,358.3,27339,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,27339,1,3,0)
 ;;=3^DM Type 1 w/ Diabetic Foot Ulcer
 ;;^UTILITY(U,$J,358.3,27339,1,4,0)
 ;;=4^E10.621
 ;;^UTILITY(U,$J,358.3,27339,2)
 ;;=^5002616
 ;;^UTILITY(U,$J,358.3,27340,0)
 ;;=E10.622^^132^1312^11
 ;;^UTILITY(U,$J,358.3,27340,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,27340,1,3,0)
 ;;=3^DM Type 1 w/ Skin Ulcer
 ;;^UTILITY(U,$J,358.3,27340,1,4,0)
 ;;=4^E10.622
 ;;^UTILITY(U,$J,358.3,27340,2)
 ;;=^5002617
 ;;^UTILITY(U,$J,358.3,27341,0)
 ;;=E10.65^^132^1312^10
 ;;^UTILITY(U,$J,358.3,27341,1,0)
 ;;=^358.31IA^4^2
